Objectives: To examine the effects of specific interventions on biosimilar glargine insulin (BGI) prescribing in general practices and to analyse the influence of prescriber and economic impact.
Design: Non randomized controlled study.
Setting: General practices in 2 health areas of Seville, intervention and control group.
Objective: To analyze the impact of a strategy on the suitability of canaglizozin, and its level of acceptance, after issuing recommendations based on drug surveillance alerts issued by the Spanish Medicines and Medical Devices Agency (AEMPS).
Design: A prospective intervention from may 2016 to october 2016. Location: South Seville Health Management Area.